# Post-market Registry to Assess the Clinical Performance and Safety of the Passeo-18 Lux in Infrainguinal Arteries

Study · id `cardio:ct-nct05175703` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05175703](<https://clinicaltrials.gov/study/NCT05175703>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05175703

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 200 participants.

## Technical summary

Registry record NCT05175703. Allocation not applicable; no masking; primary purpose treatment. Start 2018-03-05 (actual); primary completion 2021-08-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT05175703, source copy `cardio:ctgov-nct05175703-2022-01-04`, retrieved 2026-10-31)
- Started: 2018-03-05 (actual) (ClinicalTrials.gov record NCT05175703, source copy `cardio:ctgov-nct05175703-2022-01-04`, retrieved 2026-10-31)
- Primary completion: 2021-08-31 (actual) (ClinicalTrials.gov record NCT05175703, source copy `cardio:ctgov-nct05175703-2022-01-04`, retrieved 2026-10-31)
- Completion: 2022-01-31 (anticipated) (ClinicalTrials.gov record NCT05175703, source copy `cardio:ctgov-nct05175703-2022-01-04`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT05175703, source copy `cardio:ctgov-nct05175703-2022-01-04`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05175703-2022-01-04`, retrieved 2026-10-31)

## The registry's words

- Brief title: Post-market Registry to Assess the Clinical Performance and Safety of the Passeo-18 Lux in Infrainguinal Arteries
- Condition: Angioplasty, Balloon
- Condition: Disease, Peripheral Artery
- Intervention (Device): Passeo-18 Lux Paclitaxel releasing Balloon Catheter
- Lead sponsor: Ajou University School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Ajou University School of Medicine (`cardio:org-ajou-university-school-of-medicine`)

## Provenance

Content hash: ca9360f3ffb01f7ff84d5cd676a467fc3ab7882e19621fbc2e3276a4d5e9382e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
